AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.

JPM Healthcare Conference 2026

The 44th Annual J.P. Morgan Healthcare Conference is widely considered the most influential healthcare investment meeting in the world. Often described as the “Super Bowl of Healthcare”, it brings together more than 8,000 participants, including C-suite executives, institutional investors, policymakers, analysts and media.

HOVR New Horizon Aircraft Ltd

Government money and Formula 1 DNA behind the Cavorite X7
In October 2025 Horizon announced an INSAT (Initiative for Sustainable Aviation Technology) grant to fund “Project CRYSTAL”, a 10.5 M CAD all-weather eVTOL programme focused on icing detection and protection. Horizon will receive about 2.0 M CAD in non-dilutive proceeds, working with the Flight Test Centre of Excellence (3C) and the University of Toronto on a propulsion system that can operate in conditions where most helicopters are grounded.

OPEN Opendoor Technologies Inc

Huge 2025 comeback – after trading below 1 USD, OPEN staged a massive rebound, with the share price up roughly 400–450% in 2025 on the back of retail enthusiasm, leadership changes and a “short squeeze” narrative.
Real business, real losses – this is not a pre-revenue story. Opendoor generated 3.635B USD of revenue in the first nine months of 2025, but still reported a net loss of 204M USD over the same period.
Heavy balance sheet usage – the company ended Q3 2025 with 962M USD of cash and 1.79B USD of debt, for a net cash position of about −830M USD. This is not an asset-light software-only model.

TMC TMC the metals company Inc

TMC is not a traditional small biotech or junior miner. It is a high-beta small/mid cap trying to open an entirely new segment: harvesting polymetallic nodules on the ocean floor in the Clarion-Clipperton Zone, with the idea of feeding the electric-vehicle and strategic metals supply chain.

In 2025 the stock moved from just above 1 USD to a peak above 11 USD, closing the year still several hundred percent above the starting point. That kind of move puts TMC firmly on any “small caps of the moment” radar: strong narrative, strong retail interest, highly directional.

Nasdaq Delisting & Compliance 101

A practical guide for small traders: how the Nasdaq $1 rule really works, what “extensions” mean, and what the historic market reactions look like.

This article is informational and educational only. It is not legal advice, not investment advice and not a recommendation to buy, sell or hold any security.

RunUp Biotech 2026

RunUp26

This guide is the core pillar of the Run-Up Biotech 2026 framework. It is designed as a reference map for event-driven traders who want to follow biotech catalysts in a more structured way: from calendar building and candidate selection to timing, risk management and post-event review.

MARKET REPORT – WEEK 15–19 DECEMBER 2025

The coming week looks like a genuine pivot week for global markets, with three macro catalysts in sequence that will reshape expectations on rates, growth and inflation. The backdrop is a rotation into small caps and cyclicals, supported by a Fed that has shifted into a less aggressive “pause” mode and by a potential divergence between central banks: the BoE is expected to cut (18 Dec), the ECB is likely to stay on hold, and US CPI (18 Dec) together with labour data will refine the timing of 2026 rate cuts.

FDA PDUFA Catalyst Report-January 2026

English Italiano FDA PDUFA Catalyst Report – January 2026 Report Catalysts FDA PDUFA – Gennaio 2026 Key biotech approval events with price scenarios and qualitative sentiment for active traders. Principali eventi di approvazione biotech con scenari di prezzo e sentiment…

Trending now

Conceptual illustration of minerals, mining, electricity infrastructure and a data center at dusk.
Minerals, Megawatts and Money: The Race From Strategic Assets to Shareholder Returns — $BE, $OKLO, $LAC, $CRML
Merlintrader Biotech Radar, October 7, 2026: $ARWR, $ARVN, $LPCN, $MAIA and $RNXT; conceptual laboratory and molecular illustration.
Biotech Radar, October 7: regulatory progress, Parkinson’s data and oncology milestones
Illustration of the liver and metabolic research, with the original Merlintrader logo and ALT, VKTX, IVA and MDGL tickers.
MASH beyond weight loss: what $ALT, $VKTX, $IVA and $MDGL actually have to prove
Illustration of red blood cells and sickled cells, with the original Merlintrader logo and AGIO, CRSP, BEAM and NVO tickers.
Sickle cell: what progress means for $AGIO, $CRSP, $BEAM and $NVO